General
Preferred name
NYSTATIN
Synonyms
Multilind ()
Nystaform ()
Mikostatin ()
Nystavescent ()
Myco 20 ()
Nystex ()
Nysert ()
Candex ()
Korostatin ()
Nyspes ()
Nystan Triple Pack ()
Tinaderm M ()
Barstatin 100 ()
Terrastatin ()
Infestat ()
Mycostatin ()
Mykinac ()
Nystatinum ()
Nilstat ()
NSC-150817 ()
Nystop ()
L-nystatin ()
P&D ID
PD071899
CAS
1400-61-9
Tags
natural product
drug
available
Approved by
FDA
First approval
1964
Drug Status
approved
vet_approved
Max Phase
Phase 4
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Cell lines
1
Organisms
8
Compound Sets
8
ChEMBL Approved Drugs
ChEMBL Drugs
Drug Repurposing Hub
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
ReFrame library
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
29
Properties
(calculated by RDKit )
Molecular Weight
925.5
Hydrogen Bond Acceptors
17
Hydrogen Bond Donors
12
Rotatable Bonds
3
Ring Count
3
Aromatic Ring Count
0
cLogP
0.94
TPSA
319.61
Fraction CSP3
0.7
Chiral centers
19.0
Largest ring
36.0
QED
0.18
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Target
Fungal
Pathway
Anti-infection
Apoptosis
Indication
esophageal candidiasis, skin infections, yeast infection
MOA
fungal ergosterol inhibitor
Source data
